25 XP   0   0   10

Immuron Ltd
Buy, Hold or Sell?

Let's analyse Immuron together

PenkeI guess you are interested in Immuron Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Immuron Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Immuron Ltd

I send you an email if I find something interesting about Immuron Ltd.

Quick analysis of Immuron (30 sec.)










What can you expect buying and holding a share of Immuron? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.09
Expected worth in 1 year
A$0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.06
Return On Investment
-59.5%

For what price can you sell your share?

Current Price per Share
A$0.11
Expected price per share
A$0.091 - A$0.135
How sure are you?
50%

1. Valuation of Immuron (5 min.)




Live pricePrice per Share (EOD)

A$0.11

Intrinsic Value Per Share

A$-0.12 - A$-0.07

Total Value Per Share

A$-0.04 - A$0.02

2. Growth of Immuron (5 min.)




Is Immuron growing?

Current yearPrevious yearGrowGrow %
How rich?$12.7m$15m-$2.3m-18.2%

How much money is Immuron making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$1.8m-$605.8k-24.6%
Net Profit Margin-209.8%-373.0%--

How much money comes from the company's main activities?

3. Financial Health of Immuron (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#644 / 1010

Most Revenue
#487 / 1010

Most Profit
#328 / 1010

Most Efficient
#633 / 1010

What can you expect buying and holding a share of Immuron? (5 min.)

Welcome investor! Immuron's management wants to use your money to grow the business. In return you get a share of Immuron.

What can you expect buying and holding a share of Immuron?

First you should know what it really means to hold a share of Immuron. And how you can make/lose money.

Speculation

The Price per Share of Immuron is A$0.105. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Immuron.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Immuron, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.09. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Immuron.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-10.3%-0.01-10.3%-0.01-7.8%-0.01-12.3%-0.01-11.9%
Usd Book Value Change Per Share-0.01-9.7%-0.01-9.7%-0.01-7.4%0.016.1%0.015.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-9.7%-0.01-9.7%-0.01-7.4%0.016.1%0.015.3%
Usd Price Per Share0.05-0.05-0.05-0.09-0.12-
Price to Earnings Ratio-4.51--4.51--6.30--8.25--10.19-
Price-to-Total Gains Ratio-4.80--4.80--6.62--13.89-3.03-
Price to Book Ratio0.87-0.87-0.78-3.45-6.32-
Price-to-Total Gains Ratio-4.80--4.80--6.62--13.89-3.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0682395
Number of shares14654
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.01
Gains per Quarter (14654 shares)-148.8693.46
Gains per Year (14654 shares)-595.44373.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-595-6050374364
20-1191-12000748738
30-1786-1795011221112
40-2382-2390014951486
50-2977-2985018691860
60-3573-3580022432234
70-4168-4175026172608
80-4763-4770029912982
90-5359-5365033653356
100-5954-5960037383730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.022.02.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%10.014.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%10.014.00.041.7%

Fundamentals of Immuron

About Immuron Ltd

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers' diarrhea in the United States, and Travelers' Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Fundamental data was last updated by Penke on 2024-04-22 09:55:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Immuron Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Immuron earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • A Net Profit Margin of -209.8% means that $-2.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immuron Ltd:

  • The MRQ is -209.8%. The company is making a huge loss. -2
  • The TTM is -209.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-209.8%TTM-209.8%0.0%
TTM-209.8%YOY-373.0%+163.2%
TTM-209.8%5Y-1,329.0%+1,119.2%
5Y-1,329.0%10Y-851.4%-477.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-209.8%-207.2%-2.6%
TTM-209.8%-216.8%+7.0%
YOY-373.0%-282.3%-90.7%
5Y-1,329.0%-436.8%-892.2%
10Y-851.4%-597.3%-254.1%
1.1.2. Return on Assets

Shows how efficient Immuron is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • -17.2% Return on Assets means that Immuron generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immuron Ltd:

  • The MRQ is -17.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.2%TTM-17.2%0.0%
TTM-17.2%YOY-11.5%-5.7%
TTM-17.2%5Y-32.2%+15.0%
5Y-32.2%10Y-44.8%+12.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.2%-13.3%-3.9%
TTM-17.2%-12.8%-4.4%
YOY-11.5%-11.6%+0.1%
5Y-32.2%-13.8%-18.4%
10Y-44.8%-15.6%-29.2%
1.1.3. Return on Equity

Shows how efficient Immuron is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • -19.3% Return on Equity means Immuron generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immuron Ltd:

  • The MRQ is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.3%TTM-19.3%0.0%
TTM-19.3%YOY-12.3%-7.0%
TTM-19.3%5Y-35.8%+16.5%
5Y-35.8%10Y-57.9%+22.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.3%-16.9%-2.4%
TTM-19.3%-16.1%-3.2%
YOY-12.3%-14.9%+2.6%
5Y-35.8%-19.3%-16.5%
10Y-57.9%-20.1%-37.8%

1.2. Operating Efficiency of Immuron Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Immuron is operating .

  • Measures how much profit Immuron makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • An Operating Margin of -332.5% means the company generated $-3.32  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immuron Ltd:

  • The MRQ is -332.5%. The company is operating very inefficient. -2
  • The TTM is -332.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-332.5%TTM-332.5%0.0%
TTM-332.5%YOY-530.5%+198.0%
TTM-332.5%5Y-1,392.7%+1,060.2%
5Y-1,392.7%10Y-868.0%-524.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-332.5%-298.0%-34.5%
TTM-332.5%-238.5%-94.0%
YOY-530.5%-288.4%-242.1%
5Y-1,392.7%-486.2%-906.5%
10Y-868.0%-628.4%-239.6%
1.2.2. Operating Ratio

Measures how efficient Immuron is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.32 means that the operating costs are $4.32 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Immuron Ltd:

  • The MRQ is 4.325. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.325. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.325TTM4.3250.000
TTM4.325YOY6.305-1.980
TTM4.3255Y14.927-10.602
5Y14.92710Y9.771+5.156
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3253.235+1.090
TTM4.3253.310+1.015
YOY6.3053.838+2.467
5Y14.9275.679+9.248
10Y9.7717.823+1.948

1.3. Liquidity of Immuron Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Immuron is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.20 means the company has $9.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Immuron Ltd:

  • The MRQ is 9.197. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.197. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.197TTM9.1970.000
TTM9.197YOY15.750-6.553
TTM9.1975Y12.406-3.209
5Y12.40610Y9.066+3.340
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1973.863+5.334
TTM9.1974.169+5.028
YOY15.7505.337+10.413
5Y12.4066.122+6.284
10Y9.0666.434+2.632
1.3.2. Quick Ratio

Measures if Immuron is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • A Quick Ratio of 9.57 means the company can pay off $9.57 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immuron Ltd:

  • The MRQ is 9.574. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.574. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.574TTM9.5740.000
TTM9.574YOY16.372-6.799
TTM9.5745Y12.119-2.545
5Y12.11910Y8.430+3.689
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5743.504+6.070
TTM9.5743.991+5.583
YOY16.3725.371+11.001
5Y12.1196.088+6.031
10Y8.4306.395+2.035

1.4. Solvency of Immuron Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Immuron assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Immuron to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Immuron assets are financed with 10.8% credit (debt) and the remaining percentage (100% - 10.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Immuron Ltd:

  • The MRQ is 0.108. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.108. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.108TTM0.1080.000
TTM0.108YOY0.068+0.040
TTM0.1085Y0.090+0.018
5Y0.09010Y0.156-0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1080.339-0.231
TTM0.1080.337-0.229
YOY0.0680.271-0.203
5Y0.0900.368-0.278
10Y0.1560.388-0.232
1.4.2. Debt to Equity Ratio

Measures if Immuron is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Immuron to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.1% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immuron Ltd:

  • The MRQ is 0.121. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.121. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.121TTM0.1210.000
TTM0.121YOY0.072+0.048
TTM0.1215Y0.100+0.021
5Y0.10010Y0.213-0.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1210.392-0.271
TTM0.1210.403-0.282
YOY0.0720.335-0.263
5Y0.1000.427-0.327
10Y0.2130.461-0.248

2. Market Valuation of Immuron Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Immuron generates.

  • Above 15 is considered overpriced but always compare Immuron to the Biotechnology industry mean.
  • A PE ratio of -4.51 means the investor is paying $-4.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immuron Ltd:

  • The EOD is -6.317. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.512. Based on the earnings, the company is expensive. -2
  • The TTM is -4.512. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.317MRQ-4.512-1.805
MRQ-4.512TTM-4.5120.000
TTM-4.512YOY-6.305+1.793
TTM-4.5125Y-8.254+3.742
5Y-8.25410Y-10.185+1.932
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.317-2.300-4.017
MRQ-4.512-2.656-1.856
TTM-4.512-2.718-1.794
YOY-6.305-4.145-2.160
5Y-8.254-6.258-1.996
10Y-10.185-6.315-3.870
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Immuron Ltd:

  • The EOD is -9.582. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.844. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.844. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.582MRQ-6.844-2.738
MRQ-6.844TTM-6.8440.000
TTM-6.844YOY-5.727-1.117
TTM-6.8445Y-11.075+4.231
5Y-11.07510Y-11.482+0.407
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.582-2.974-6.608
MRQ-6.844-3.306-3.538
TTM-6.844-3.508-3.336
YOY-5.727-5.613-0.114
5Y-11.075-8.378-2.697
10Y-11.482-8.873-2.609
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Immuron is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.87 means the investor is paying $0.87 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Immuron Ltd:

  • The EOD is 1.219. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.871. Based on the equity, the company is cheap. +2
  • The TTM is 0.871. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.219MRQ0.871+0.348
MRQ0.871TTM0.8710.000
TTM0.871YOY0.776+0.094
TTM0.8715Y3.454-2.583
5Y3.45410Y6.318-2.864
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2191.914-0.695
MRQ0.8712.116-1.245
TTM0.8712.097-1.226
YOY0.7762.881-2.105
5Y3.4543.550-0.096
10Y6.3183.936+2.382
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Immuron Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Immuron Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.0160%-0.012-24%0.010-259%0.009-283%
Book Value Per Share--0.0860.0860%0.102-15%0.072+20%0.049+76%
Current Ratio--9.1979.1970%15.750-42%12.406-26%9.066+1%
Debt To Asset Ratio--0.1080.1080%0.068+60%0.090+20%0.156-31%
Debt To Equity Ratio--0.1210.1210%0.072+67%0.100+20%0.213-43%
Dividend Per Share----0%-0%-0%-0%
Eps---0.017-0.0170%-0.013-25%-0.020+19%-0.019+16%
Free Cash Flow Per Share---0.011-0.0110%-0.014+26%-0.013+18%-0.016+45%
Free Cash Flow To Equity Per Share---0.011-0.0110%-0.014+26%0.013-185%0.008-238%
Gross Profit Margin--1.2451.2450%1.146+9%1.182+5%1.133+10%
Intrinsic Value_10Y_max---0.066--------
Intrinsic Value_10Y_min---0.124--------
Intrinsic Value_1Y_max---0.012--------
Intrinsic Value_1Y_min---0.015--------
Intrinsic Value_3Y_max---0.031--------
Intrinsic Value_3Y_min---0.043--------
Intrinsic Value_5Y_max---0.046--------
Intrinsic Value_5Y_min---0.069--------
Market Cap23918790.000+29%17084875.95017084875.9500%17996042.000-5%31618367.590-46%40753064.795-58%
Net Profit Margin---2.098-2.0980%-3.730+78%-13.290+533%-8.514+306%
Operating Margin---3.325-3.3250%-5.305+60%-13.927+319%-8.680+161%
Operating Ratio--4.3254.3250%6.305-31%14.927-71%9.771-56%
Pb Ratio1.219+29%0.8710.8710%0.776+12%3.454-75%6.318-86%
Pe Ratio-6.317-40%-4.512-4.5120%-6.305+40%-8.254+83%-10.185+126%
Price Per Share0.105+29%0.0750.0750%0.079-5%0.139-46%0.179-58%
Price To Free Cash Flow Ratio-9.582-40%-6.844-6.8440%-5.727-16%-11.075+62%-11.482+68%
Price To Total Gains Ratio-6.718-40%-4.798-4.7980%-6.622+38%-13.887+189%3.031-258%
Quick Ratio--9.5749.5740%16.372-42%12.119-21%8.430+14%
Return On Assets---0.172-0.1720%-0.115-33%-0.322+87%-0.448+160%
Return On Equity---0.193-0.1930%-0.123-36%-0.358+86%-0.579+200%
Total Gains Per Share---0.016-0.0160%-0.012-24%0.010-259%0.009-283%
Usd Book Value--12748981.71612748981.7160%15062992.910-15%10617330.903+20%7263735.120+76%
Usd Book Value Change Per Share---0.010-0.0100%-0.008-24%0.006-259%0.006-283%
Usd Book Value Per Share--0.0560.0560%0.066-15%0.047+20%0.032+76%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.011-0.0110%-0.008-25%-0.013+19%-0.013+16%
Usd Free Cash Flow---1622321.324-1622321.3240%-2042141.776+26%-1910016.326+18%-2347235.511+45%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.009+26%-0.008+18%-0.010+45%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%-0.009+26%0.009-185%0.005-238%
Usd Market Cap15544821.621+29%11103460.88011103460.8800%11695627.696-5%20548777.097-46%26485416.810-58%
Usd Price Per Share0.068+29%0.0490.0490%0.051-5%0.090-46%0.116-58%
Usd Profit---2460850.899-2460850.8990%-1854979.675-25%-2937182.886+19%-2906184.541+18%
Usd Revenue--1172877.7801172877.7800%497298.931+136%990664.147+18%903905.031+30%
Usd Total Gains Per Share---0.010-0.0100%-0.008-24%0.006-259%0.006-283%
 EOD+5 -3MRQTTM+0 -0YOY+13 -215Y+19 -1510Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of Immuron Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.317
Price to Book Ratio (EOD)Between0-11.219
Net Profit Margin (MRQ)Greater than0-2.098
Operating Margin (MRQ)Greater than0-3.325
Quick Ratio (MRQ)Greater than19.574
Current Ratio (MRQ)Greater than19.197
Debt to Asset Ratio (MRQ)Less than10.108
Debt to Equity Ratio (MRQ)Less than10.121
Return on Equity (MRQ)Greater than0.15-0.193
Return on Assets (MRQ)Greater than0.05-0.172
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Immuron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.105
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets21,988
Total Liabilities2,371
Total Stockholder Equity19,617
 As reported
Total Liabilities 2,371
Total Stockholder Equity+ 19,617
Total Assets = 21,988

Assets

Total Assets21,988
Total Current Assets20,409
Long-term Assets1,579
Total Current Assets
Cash And Cash Equivalents 17,160
Short-term Investments 1,834
Net Receivables 417
Inventory 840
Other Current Assets 158
Total Current Assets  (as reported)20,409
Total Current Assets  (calculated)20,409
+/-0
Long-term Assets
Property Plant Equipment 200
Long Term Investments 159
Long-term Assets Other 1,220
Long-term Assets  (as reported)1,579
Long-term Assets  (calculated)1,579
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,219
Long-term Liabilities152
Total Stockholder Equity19,617
Total Current Liabilities
Short-term Debt 39
Accounts payable 791
Other Current Liabilities 691
Total Current Liabilities  (as reported)2,219
Total Current Liabilities  (calculated)1,521
+/- 698
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt150
Other Liabilities 2
Long-term Liabilities  (as reported)152
Long-term Liabilities  (calculated)152
+/- 0
Total Stockholder Equity
Common Stock88,436
Retained Earnings -72,055
Accumulated Other Comprehensive Income 3,236
Total Stockholder Equity (as reported)19,617
Total Stockholder Equity (calculated)19,617
+/-0
Other
Capital Stock88,436
Cash and Short Term Investments 18,994
Common Stock Shares Outstanding 227,798
Current Deferred Revenue698
Liabilities and Stockholders Equity 21,988
Net Debt -16,971
Net Invested Capital 19,617
Net Tangible Assets 19,617
Net Working Capital 18,190
Property Plant and Equipment Gross 651
Short Long Term Debt Total 189



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
0
4,503
7,831
6,577
5,955
4,910
8,055
6,625
3,296
1,900
493
3,798
2,660
3,638
2,527
7,632
4,549
8,827
8,286
9,243
8,562
6,202
27,053
24,856
21,988
21,98824,85627,0536,2028,5629,2438,2868,8274,5497,6322,5273,6382,6603,7984931,9003,2966,6258,0554,9105,9556,5777,8314,5030
   > Total Current Assets 
0
0
5,563
4,365
0
2,848
6,041
4,998
2,654
1,677
422
2,306
1,171
2,219
1,838
7,612
4,529
8,809
8,268
7,050
6,682
4,409
25,753
23,672
20,409
20,40923,67225,7534,4096,6827,0508,2688,8094,5297,6121,8382,2191,1712,3064221,6772,6544,9986,0412,84804,3655,56300
       Cash And Cash Equivalents 
0
356
307
576
382
312
179
1,434
673
1,091
150
1,882
751
1,444
1,447
6,142
3,116
2,291
3,995
4,727
5,120
3,250
25,047
22,110
17,160
17,16022,11025,0473,2505,1204,7273,9952,2913,1166,1421,4471,4447511,8821501,0916731,4341793123825763073560
       Short-term Investments 
0
4,000
4,536
2,800
2,130
1,000
3,479
1,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,834
1,834
1,8341,8340000000000000001,1003,4791,0002,1302,8004,5364,0000
       Net Receivables 
0
29
389
520
654
605
968
816
1,011
269
28
153
34
205
15
518
222
4,388
1,768
1,683
969
328
335
663
417
4176633353289691,6831,7684,3882225181520534153282691,011816968605654520389290
       Other Current Assets 
0
21
15
40
47
128
126
59
145
155
148
249
96
356
84
387
45
481
305
142
49
33
78
572
158
15857278334914230548145387843569624914815514559126128474015210
   > Long-term Assets 
0
0
2,269
2,212
0
2,062
2,014
0
0
0
0
1,492
1,489
1,419
689
0
0
18
19
2,192
1,879
1,793
1,300
1,184
1,579
1,5791,1841,3001,7931,8792,1921918006891,4191,4891,49200002,0142,06202,2122,26900
       Property Plant Equipment 
0
7
1,922
1,883
1,830
1,769
1,739
1,627
642
223
71
31
28
18
8
20
20
18
19
20
17
71
34
227
200
20022734711720191820208182831712236421,6271,7391,7691,8301,8831,92270
       Goodwill 
0
0
347
329
311
293
275
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000027529331132934700
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159
159000000000000000000000000
       Intangible Assets 
0
0
347
329
311
293
275
0
0
0
0
1,461
1,461
1,401
681
0
0
0
0
0
0
0
0
0
0
00000000006811,4011,4611,461000027529331132934700
       Other Assets 
0
0
0
0
0
2,062
2,014
1,627
642
223
71
1,492
1,489
1,419
689
20
20
800
0
2,172
1,862
0
1,267
0
0
001,26701,8622,172080020206891,4191,4891,492712236421,6272,0142,06200000
> Total Liabilities 
0
61
356
254
911
878
1,114
1,447
1,376
813
678
435
928
1,588
2,382
845
1,208
3,887
1,712
803
1,211
558
1,158
1,678
2,371
2,3711,6781,1585581,2118031,7123,8871,2088452,3821,5889284356788131,3761,4471,114878911254356610
   > Total Current Liabilities 
0
61
356
254
870
832
1,092
1,386
1,312
790
676
433
928
1,029
1,235
845
1,208
3,887
1,712
803
1,196
516
1,122
1,503
2,219
2,2191,5031,1225161,1968031,7123,8871,2088451,2351,0299284336767901,3121,3861,092832870254356610
       Short-term Debt 
0
0
4,536
2,800
0
27
3,479
1,100
0
0
0
0
0
0
0
0
0
1,901
366
0
42
42
20
34
39
393420424203661,9010000000001,1003,4792702,8004,53600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,901
366
0
0
0
0
0
0
0000003661,90100000000000000000
       Accounts payable 
0
37
212
173
427
515
673
899
683
213
195
276
329
426
779
653
918
1,517
700
217
715
158
107
721
791
7917211071587152177001,517918653779426329276195213683899673515427173212370
       Other Current Liabilities 
0
24
-4,473
-2,748
433
127
318
205
429
64
108
157
599
81
4
193
289
469
627
586
480
317
994
748
691
69174899431748058662746928919348159915710864429205318127433-2,748-4,473240
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
2
2
0
560
1,146
0
0
0
0
0
15
42
36
175
152
152175364215000001,1465600220000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
0
0
0
00019000000000000000000000
       Other Liabilities 
0
0
0
0
14
47
23
60
64
23
2
2
0
0
0
0
0
0
0
0
15
23
36
0
2
2036231500000000222364602347140000
> Total Stockholder Equity
0
4,442
7,475
6,323
5,043
4,031
6,940
5,179
1,920
1,087
-185
3,363
1,732
2,050
145
6,787
3,341
4,941
6,575
8,439
7,351
5,644
25,895
23,177
19,617
19,61723,17725,8955,6447,3518,4396,5754,9413,3416,7871452,0501,7323,363-1851,0871,9205,1796,9404,0315,0436,3237,4754,4420
   Common Stock
0
7,458
12,045
12,592
12,592
12,742
16,985
18,730
18,751
20,583
21,459
26,964
27,722
30,025
31,358
40,325
40,335
45,633
53,633
58,372
60,511
62,427
88,361
88,436
88,436
88,43688,43688,36162,42760,51158,37253,63345,63340,33540,32531,35830,02527,72226,96421,45920,58318,75118,73016,98512,74212,59212,59212,0457,4580
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-40
-173
0
-479
-645
78
80
273
443
388
595
907
1,208
667
548
2,129
2,470
2,607
3,700
1,133
3,467
3,166
3,236
3,2363,1663,4671,1333,7002,6072,4702,1295486671,2089075953884432738078-645-4790-173-4000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
667
548
2,129
2,470
2,607
4,300
1,133
3,467
3,166
112
1123,1663,4671,1334,3002,6072,4702,129548667000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue1,805
Cost of Revenue-496
Gross Profit1,3091,309
 
Operating Income (+$)
Gross Profit1,309
Operating Expense-7,310
Operating Income-6,000-6,000
 
Operating Expense (+$)
Research Development2,592
Selling General Administrative4,221
Selling And Marketing Expenses927
Operating Expense7,3107,740
 
Net Interest Income (+$)
Interest Income107
Interest Expense-10
Other Finance Cost-10
Net Interest Income107
 
Pretax Income (+$)
Operating Income-6,000
Net Interest Income107
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,855-8,146
EBIT - interestExpense = -6,010
-4,179
-3,777
Interest Expense10
Earnings Before Interest and Taxes (EBIT)-6,000-3,845
Earnings Before Interest and Taxes (EBITDA)-5,952
 
After tax Income (+$)
Income Before Tax-3,855
Tax Provision-0
Net Income From Continuing Ops-3,787-3,855
Net Income-3,787
Net Income Applicable To Common Shares-3,787
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,805
Total Other Income/Expenses Net2,145-107
 

Technical Analysis of Immuron
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Immuron. The general trend of Immuron is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Immuron's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Immuron Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.105 < 0.13 < 0.135.

The bearish price targets are: 0.096 > 0.094 > 0.091.

Tweet this
Immuron Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Immuron Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Immuron Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Immuron Ltd.

Immuron Ltd Daily Moving Average Convergence/Divergence (MACD) ChartImmuron Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Immuron Ltd. The current adx is .

Immuron Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Immuron Ltd.

Immuron Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Immuron Ltd.

Immuron Ltd Daily Relative Strength Index (RSI) ChartImmuron Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Immuron Ltd.

Immuron Ltd Daily Stochastic Oscillator ChartImmuron Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Immuron Ltd.

Immuron Ltd Daily Commodity Channel Index (CCI) ChartImmuron Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Immuron Ltd.

Immuron Ltd Daily Chande Momentum Oscillator (CMO) ChartImmuron Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Immuron Ltd.

Immuron Ltd Daily Williams %R ChartImmuron Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Immuron Ltd.

Immuron Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Immuron Ltd.

Immuron Ltd Daily Average True Range (ATR) ChartImmuron Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Immuron Ltd.

Immuron Ltd Daily On-Balance Volume (OBV) ChartImmuron Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Immuron Ltd.

Immuron Ltd Daily Money Flow Index (MFI) ChartImmuron Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Immuron Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Immuron Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Immuron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.105
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Immuron with someone you think should read this too:
  • Are you bullish or bearish on Immuron? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Immuron? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Immuron Ltd

I send you an email if I find something interesting about Immuron Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Immuron Ltd.

Receive notifications about Immuron Ltd in your mailbox!